Both in Biotechnology
Amgen vs Neurocrine Biosciences
Over the past year AMGN returned +57.1% and NBIX returned +2.4%; their daily moves had a correlation of 0.28.
AMGN +57.1% NBIX +2.4%Growth of $1, one year, split-adjusted
| Metric | AMGN | NBIX |
|---|---|---|
| Price | $465.45 | $145.35 |
| Market cap | $251.64B | $14.77B |
| Today | −0.12% | −0.51% |
| 1 month | +15.5% | +1.5% |
| 6 months | +43.7% | +8.4% |
| Year to date | +42.2% | +2.5% |
| 1 year | +59.4% | +5.3% |
| Revenue growth (YoY) | +9.5% | +39.5% |
| Gross margin | 72.0% | 97.6% |
| Net margin | 23.6% | 15.1% |
| P/E (TTM) | 28.8× | 20.9× |
| Price / sales | 6.6× | 4.4× |
| Net cash | -$43.31B | $389.8M |
| Dividend yield | 2.17% | — |
| Volatility (60d) | 33.1% | 25.9% |
| Short % of float | 2.5% | 6.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).